Petersen PC, Petersen LN, Vogelius I, Bjerregaard JK, Baeksgaard L. A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma. AO [Internet]. 2021 Jul. 3 [cited 2026 Jun. 27];60(7):948-53. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24015